Division of Pharmaceutical Technology and Biopharmacy
Division of Pharmaceutical Technology and Biopharmacy
Division of Pharmaceutical Technology and Biopharmacy
Prof. Dr. Dagmar Fischer
The Fischer group is focussed on the development of natural and synthetic micro- and nanocarriers for drug delivery in the field of infection, inflammation and inflammation-related diseases as well as aging. A major focus is related to biopharmaceutical test systems according to the 3R principle to investigate the life cycle of drug delivery systems and the influence of the physiological environment. Furthermore, nanosafety and safe-by-design concepts as well as quality assurance concepts are provided
At 22 November 2024 11 c.t. Prof. Fischer will give a lunch break seminar entiteled „Sustainability in pharmaceutical formulations“ in efs-NeW.
Further information:
Emil Fischer Graduate Programme / FAU NeW
A warm welcome to Francesca Mancusi from the University of Firenze! She joint our lab as visiting scientist for 6 months as part of her PhD thesis.
Francesca, we wish you a great and sucessfull time here in Erlangen!
We are happy to announce that Dr. Mona Mahmoud joint today the TEL-Drug Delivery project and supports the projectteam with her biological and drug delivery expertise.
We wish you a good and sucessfull start!
Gesa Waßmuth presented her latest research in the TEL-Drug Delivey Project with the title "Archaeal Tetraether Lipids as a Platform for the Oral Application of mRNA Vaccines" at the Annual Meeting of the German Society for Biomaterials, from 10-12 October in Berlin. The project is funded by the Bund...
Congratulations to Carolina Corell! She sucessfully defended her thesis with the title „Formulation of poorly water-soluble pharmaceutical active ingredients by spray drying using three-fluid nozzle atomization“.
On July 11, 2024 Fabian Döll gave a talk at the Research Day of the Emil Fischer Graduate Programme (efs-NeW) in the FAU Research Centre “New Bioactive Compounds” (FAU NeW) entiteled „Development of a Selective Antimicrobial Cystic Fibrosis Therapy Approach“.
Jan Westhoff visits the Quantum and Nanotechnology Research Centre (NINT) at the National Research Council Canada in Edmonton, Alberta for three months as a member of the CRC PolyTarget (www.polytarget.de) to strengthen our collaboration in the field of polymer nanoparticles.
Sandra Hübner and Jan Egger will present their latest research in the field of polymer based drug delivery as innovative gene delivery systems (B03 (uni-jena.de) and sonosensitive drug application in cancer.
https://2024crsannualmeeting.eventscribe.net/
